Evaluation of Dapagliflozin Taken Twice-daily

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

dapagliflozin

2.5 mg tablet, taken orally, twice daily

DRUG

dapagliflozin

5 mg tablet taken orally, twice daily

DRUG

dapagliflozin

10 mg tablet taken orally, once daily

DRUG

metformin

\>/= 1500 mg total daily dose, tablets taken orally, twice daily

DRUG

placebo

placebo

Trial Locations (55)

Unknown

Research Site, Aßlar

Research Site, Berlin

Research Site, Biberach A.d. Riss

Research Site, Bosenheim

Research Site, Dippoldiswalde

Research Site, Falkensee

Research Site, Meissen

Research Site, München

Research Site, Neuwied

Research Site, Pirna

Research Site, Wahlstedt

Research Site, Balatonfüred

Research Site, Budapest

Research Site, Csongrád

Research Site, Debrecen

Research Site, Gyöngyös

Research Site, Kecskemét

Research Site, Makó

Research Site, Nyíregyháza

Research Site, Tát

Research Site, Zalaegerszeg

Research Site, Brasov

Research Site, Bucharest

Research Site, Iași

Research Site, Sibiu

Research Site, Suceava

Research Site, Banská Bystrica

Research Site, Bratislava

Research Site, Dolný Kubín

Research Site, Košice

Research Site, Lučenec

Research Site, Námestovo

Research Site, Piešťany

Research Site, Prievidza

Research Site, Rimavská Sobota

Research Site, Ružomberok

Research Site, Žilina

Research Site, Verulam

Research Site, Cape Town

Research Site, Durban

Research Site, eMkhomazi

Research Site, Johannesburg

Research Site, Durban

Research Site, Chur

Research Site, Basel

Research Site, Bern

Research Site, Geneva

Research Site, Kreuzlingen

Research Site, Lugano

Research Site, Rorschach

Research Site, Vynnitsa

Research Site, Zaporizhzhya

Research Site, Dnipropetrov'sk

Research Site, Kiev

Research Site, Vinnytsia

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY